15
Participants
Start Date
January 31, 2010
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
certolizumab pegol
400mg subcutaneous injections at week 0, week 2, week 4, then every 4 weeks thereafter
Shafran Gastroenterology Center, Winter Park
Collaborators (1)
UCB Pharma
INDUSTRY
Shafran Gastroenterology Center
OTHER